Literature DB >> 8663128

The hepatitis B virus transactivator protein, HBx, interacts with single-stranded DNA (ssDNA). Biochemical characterizations of the HBx-ssDNA interactions.

I Qadri1, M E Ferrari, A Siddiqui.   

Abstract

Human hepatitis B virus X protein, HBx, is widely acknowledged as a transcriptional transactivator. While HBx has been shown to increase gene expression in trans, it is generally believed that it does not bind double-stranded DNA. Using several experimental approaches, we show that HBx interacts with single-stranded DNA in a manner that is not sequence-specific. Various heterologous single-stranded DNA (ssDNA) oligonucleotides were able to compete in HBx-ssDNA interactions in gel shift assays. Escherichia coli non-sequence-specific, single-stranded DNA binding protein, E. coli SSB, displaced the HBx-ssDNA interactions, confirming the ability of HBx to interact with single-stranded DNA in a non-sequence-specific manner. We have further characterized the HBx-ssDNA interactions under various biochemical conditions. These include the effects of mono- and divalent cations, the effect of cardiolipin and heparin, pH and temperature dependence, and variations in the incubation time. HBx bound more tightly to d(pyrimidines)25 than to d(purines)25, a property that is characteristic of other single-stranded DNA-binding proteins (SSBs). Collectively the results presented here provide the first evidence of HBx's interaction with ssDNA. The biochemical parameters of these interactions were similar to those of known viral and cellular SSBs.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8663128     DOI: 10.1074/jbc.271.26.15443

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Interaction of the UV-damaged DNA-binding protein with hepatitis B virus X protein is conserved among mammalian hepadnaviruses and restricted to transactivation-proficient X-insertion mutants.

Authors:  D Sitterlin; T H Lee; S Prigent; P Tiollais; J S Butel; C Transy
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  pX, the HBV-encoded coactivator, suppresses the phenotypes of TBP and TAFII250 mutants.

Authors:  I Haviv; Y Matza; Y Shaul
Journal:  Genes Dev       Date:  1998-04-15       Impact factor: 11.361

Review 3.  Potential mechanisms of hepatitis B virus induced liver injury.

Authors:  Mohd Suhail; Hany Abdel-Hafiz; Ashraf Ali; Kaneez Fatima; Ghazi A Damanhouri; Esam Azhar; Adeel Ga Chaudhary; Ishtiaq Qadri
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

4.  Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis.

Authors:  L W Elmore; A R Hancock; S F Chang; X W Wang; S Chang; C P Callahan; D A Geller; H Will; C C Harris
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

5.  Hepatitis B virus X protein impedes the DNA repair via its association with transcription factor, TFIIH.

Authors:  Ishtiaq Qadri; Kaneez Fatima; Hany AbdeL-Hafiz
Journal:  BMC Microbiol       Date:  2011-03-04       Impact factor: 3.605

6.  Hepatitis B virus transactivator protein, HBx, associates with the components of TFIIH and stimulates the DNA helicase activity of TFIIH.

Authors:  I Qadri; J W Conaway; R C Conaway; J Schaack; A Siddiqui
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

7.  Deregulated direct targets of the hepatitis B virus (HBV) protein, HBx, identified through chromatin immunoprecipitation and expression microarray profiling.

Authors:  Wing-Kin Sung; Yiwei Lu; Charlie W H Lee; Dongwei Zhang; Mostafa Ronaghi; Caroline G L Lee
Journal:  J Biol Chem       Date:  2009-05-13       Impact factor: 5.157

8.  Protein X of hepatitis B virus: origin and structure similarity with the central domain of DNA glycosylase.

Authors:  Formijn J van Hemert; Maarten A A van de Klundert; Vladimir V Lukashov; Neeltje A Kootstra; Ben Berkhout; Hans L Zaaijer
Journal:  PLoS One       Date:  2011-08-05       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.